CT-001 (Coagulant Therapeutics)

N/A

Report date: 2025/05/20 20:00:09

Base Information

Drug NameCT-001 (Coagulant Therapeutics)
Drug Alias NameHuman recombinant factor VIIa variant (P10Q, K32E, T106N, V253N), desialylatedCT-001CT001
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFactor VIIa replacementsCoagulation factor IX stimulantsCoagulation factor X stimulants
TargetsCoagulation factor IXCoagulation factor X
Therapy Area/IndicationsPostpartum Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoagulant Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesCoagulant Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsPostpartum Hemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A